Confluent Medical Technologies has acquired Northern Nitinol and its nitinol facility in Minneapolis. Neither company disclosed the price. Northern Nitinol handles design support, material sourcing, rapid prototyping, processing, testing and analysis for device manufacturers.

Chief executive Dean Schauer said demand for nitinol-based devices keeps growing and that Confluent will keep spending on the capabilities and infrastructure its customers need.

Prototyping turnaround is the quiet constraint on a nitinol program. A stent or a clip iterates in weeks when the shop is inside the building and in months when it is a queue at a vendor, and that gap lands squarely on a first in human timeline.